Navigation Links
Team Finance LLC Announces First Quarter 2009 Results
Date:5/6/2009

KNOXVILLE, Tenn., May 6 /PRNewswire/ -- TeamHealth Inc.'s parent company, Team Finance LLC (the "Company"), today announced results for the first quarter of 2009.

Net revenue less provision for uncollectibles ("revenue less provision") in the first quarter of 2009 increased 5.9% to $349.6 million from $330.0 million in the first quarter of 2008. Same contract revenue less provision for the quarter increased 4.4% to $319.0 million from $305.5 million in the same period a year ago. In the first quarter 2009, same contract revenue less provision benefited 4.4% from increases in estimated collections per visit while contract and other revenue contributed 0.5% to the growth. These increases were partially offset by declines in billed patient volume which resulted in a decrease in same contract revenue growth of 0.5%. New sales, net of contracts that terminated in the period, and acquisitions contributed $4.0 million and $2.1 million of growth between periods, respectively.

Based on the results of the Company's most recent actuarial study completed in April 2009, first quarter 2009 financial results reflected a reduction of professional liability reserves related to prior years of $18.8 million. A $13.8 million reduction in professional liability reserves associated with prior years was recorded during the first quarter of 2008. The most recent actuarial loss estimates reflected continued favorable trends in the development of previous loss estimates necessitating the revaluation of prior year loss reserves during the first quarter. Net earnings increased 48% to $25.9 million in the first quarter of 2009 compared to $17.5 million in the first quarter of 2008. In addition to the benefit of the prior year professional liability reserve adjustment, improvements in gross margin percentage and a decrease in net interest expense contributed to the increase in net earnings during the first quarter of 2009.

<
'/>"/>
SOURCE TeamHealth
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
2. Meth Project Chairman Testifies Before U.S. Senate Finance Committee
3. SEIU Applauds Bipartisan Leadership of Sen. Finance Committee in Push for Greater Oversight of Private Equity Takeovers of Nursing Homes
4. Kerry, Snowe Push Finance Committee on Small Business Health Care
5. Harmony Information Systems Raises $28 Million in Series B Financing from JMI Equity, Updata Partners, ORIX Venture Finance and Comerica Bank
6. OneMedPlace Emerging Healthcare Technologies Finance Forum Jan 7, 8th
7. Cardiva Medical, Inc. Appoints Two New Officers: Malcolm Farnsworth as Vice President of Finance and Chief Financial Officer and Tara Zerby as Vice President of Business Development and Marketing
8. Senate Finance Committee Recommends Ways That Medicare Can Enhance Current Physician Quality Reporting Initiative (PQRI)
9. Bush Budget Represents Double Whammy Hit on U.S. Seniors Medicare-Financed Nursing Facility Care
10. Team Finance LLC Announces Fiscal 2007 Results
11. HealthSouth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference and the 2008 Credit Suisse Global Leveraged Finance Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... December 26, 2014 The microscopy ... of 7.2% to reach $5,756.0 million by 2019. ... microscopy market. The electron microscopes product segment is ... forecast period. , Rising focus on nanotechnology, technological ... of the microscopy market. , Get Full Copy ...
(Date:12/25/2014)... 26, 2014 The click ... beauty, strength and durability. Today, the business announces ... is valid until Jan. 30, 2015. , Click ... traditional hardwood. BambooFlooringChina.com is a well-known brand in ... worldwide to find a reliable bamboo flooring supplier. ...
(Date:12/25/2014)... 2014 The report “TS-1 (Colorectal Cancer) ... the current treatment landscape, unmet needs, current pipeline and ... an anti-cancer drug which is typically used for treating ... used for treating gastric cancer and pancreatic cancer. TS-1 ... drug was first approved in 1999 in Japan for ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 “Every three months ... market changes. A-line sweetheart evening dress will be one of ... sales manager of Yunx.co.uk says. Today, the company releases 26 ... discounts, up to 80% off. , “We are trying ... unique style with our latest designs. Along with affordable prices, ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 Recently, Dylan ... dresses, has excitedly released its collection of discounted prom ... to Percy, a senior spokesman of the company, the ... of this promotion is to expand the UK market. ... in several different colors, lengths, and styles: A-line strapless, ...
Breaking Medicine News(10 mins):Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2
... Sky One,Medical, Inc. ("China Sky One Medical" or ... fully integrated pharmaceutical company producing over-the-counter,drugs in the ... it,successfully obtained the production approval from the State ... additional drugs: Sodium Cromoglicate,Eye Drops for the treatment ...
... Re Ltd., the reinsurance unit of White Mountains Insurance Group, Ltd. ... Financial Officer, will retire from full-time work at the end of ... advisor to White Mountains. , , ... the last 7 years Chuck has filled many roles within our ...
... PITTSBURGH, Dec. 16 MED3OOO, Inc., a national healthcare management, ... able to help the City of Newark, Ohio recover lost ... companies. , , After partnering ... of Newark Division Fire & EMS department is now able ...
... Dec. 16 CeloNova BioSciences, Inc., announced,today that ... U.S. Food and,Drug Administration (FDA) for Embozene(TM) Color-Advanced ... tumors (tumors with a,large number of blood vessels ... circulatory system). U.S. commercial sales of,Embozene(TM) Microspheres will ...
... Dec. 16 While all cosmetic surgery,can be performed ... feel or remember their surgery - a condition commonly ... (Photo: http://www.newscom.com/cgi-bin/prnh/20081216/LATU002 ) , ... iv sedation, pioneered by anesthesiologist Dr. Barry L.,Friedberg, is ...
... more efficiently, Fresho.com offers bulk job posting and announces new job ad ... ... NY (PRWEB) December 16, 2008 -- In order to help employers fill ... search engine Fresho.com now offers employers to submit their job openings ...
Cached Medicine News:Health News:China Sky One Medical, Inc. Obtains Production Rights for Two Additional Drugs 2Health News:China Sky One Medical, Inc. Obtains Production Rights for Two Additional Drugs 3Health News:White Mountains Re Announces Management Changes -- Chokel to Retire and Remain Risk Advisor at WTM 2Health News:White Mountains Re Announces Management Changes -- Chokel to Retire and Remain Risk Advisor at WTM 3Health News:White Mountains Re Announces Management Changes -- Chokel to Retire and Remain Risk Advisor at WTM 4Health News:City of Newark, Ohio Increases Safety Services with EMS Revenue Recovered by MED3OOO EMS Billing 2Health News:City of Newark, Ohio Increases Safety Services with EMS Revenue Recovered by MED3OOO EMS Billing 3Health News:CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform 2Health News:CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform 3Health News:CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform 4Health News:Cosmetic Surgery -'Goldilocks' Anesthesia Is Not Mickey Mouse 2Health News:Fresho.Com Offers Efficient Job Postings for Employers and Recruiters 2
(Date:12/24/2014)... Dec. 23, 2014  Lockton Dunning Benefits, the ... Companies, announced the addition of Vice President ... Lockton Dunning,s Pharmacy Consulting team, Excelsior Solutions. ... industry experience to the position.  Most recently, she ... at Diplomat Specialty Pharmacy, where she has held ...
(Date:12/24/2014)... RALEIGH, N.C. , Dec. 23, 2014 /PRNewswire/ ... (NASDAQ: ENDP ) (TSX: ENL), and BioDelivery ... today that they have submitted a New Drug Application ... Food and Drug Administration (FDA).  Buprenorphine HCl Buccal Film ... enough to require daily, around-the-clock, long-term opioid treatment and ...
(Date:12/22/2014)... Dec. 22, 2014 Apnea Sciences ( www.apneasciences.com ... in Aliso Viejo , California.  ... the tremendous growth and worldwide expansion, a new facility ... SnoreRx, the anti snore cure have exceeded our expectations ... "We are now in 23 countries and will be ...
Breaking Medicine Technology:Kim Foerster Joins Lockton Companies 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5
... 2010 Segal McCambridge Singer & Mahoney, Ltd. and ... in favor of medical device manufacturer I-Flow Corporation.  A ... the District of Oregon returned defense verdicts on all ... three plaintiffs whose cases had been consolidated for trial. ...
... Inc. (Nasdaq: SGMO ) announced today that Edward ... the progress of Sangamo,s ZFP Therapeutic® development programs and an ... on Tuesday, November 16, 2010, at the Lazard Capital Markets ... York City. A live webcast of the presentation ...
Cached Medicine Technology:Sangamo BioSciences Announces Presentation at Lazard Capital Markets Healthcare Conference 2
... Performance ,MARS Technology is the next generation ... an addition to our current family of ... advantage of new technological breakthroughs in signal ... pulse signal resulting in superior performance during ...
The NPB-40 Handheld Pulse Oximeter is both compact and affordable. It is simple to operate, provides spot-check monitoring of SpO 2 and pulse rate, and is compact enough to fit in your pocket....
... The Nellcor N-20PA Handheld Pulse Oximeter is ... The durable construction of the N-20PA has ... temperatures and conditions it has even ... is conveniently portable for spot check measurements ...
... Nellcor's most popular handheld oximeter has been ... platform and is now compatible with the ... the MAX-FAST Forehead Sensor and SoftCare Nonadhesive ... Oximeter also incorporates Nellcor's latest advanced signal ...
Medicine Products: